$33.30▾ 0.63%
End-of-day close · 2026-08-06
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
Not enough data yet
Valuation
Not enough data yet
Not enough valuation history to place this in context.
Revenue growth
Not enough data yet
Not enough revenue history to measure growth.
Leverage
Not enough data yet
Term-debt data is not available for this company.
More coming: dilution / share-count creep.
✦ The read
Viking Therapeutics, Inc.'s earnings-quality signal is not available yet.
Key numbers
Valuation
EPS (TTM)$-4.67
TTM (trailing 12 months, through fiscal Q2 FY2026)
Size
Revenue (TTM)$0.00
TTM (trailing 12 months, through fiscal Q2 FY2026)
Recent news
Sentiment · last 30 days6 articles
2 bullish2 neutral2 bearish
Viking Therapeutics Declined in July, and why its Long-Term Prospects are Undiminished
Vertex Just Paid $10 Billion for Crinetics. Here's Why Viking Therapeutics Could Be the Next Big Pharma Takeover Target
Should You Buy Viking Therapeutics Stock on the Dip? Wall Street Is Screaming "Yes."Kuehn Law Encourages Investors of Viking Therapeutics, Inc. to Contact Law Firm
Signals and key numbers are from the fiscal Q2 FY2026 filing. Price freshness: end-of-day close on Free, 15-min delayed on Pro.